EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting

Caitlin Cassidy iD, Joshua C Wiener, Karen Pratt, Laura Brunton

PM&R · 13.04.2026

DOI: 10.1002/pmrj.70135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PM&R, online erschienen am 13.04.2026. Verfasst von Caitlin Cassidy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Academic Medical Organization of Southwestern Ontario.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adolescents and adults with cerebral palsy often experience multimorbidity related to their condition, which primarily affects movement and posture but is also associated with pain, epilepsy, mood disorders, and other conditions. As such, these patients are often prescribed a range of medications to manage symptoms, thereby putting them at risk for polypharmacy.

Objectives

To determine the proportion of adolescent and adult patients with cerebral palsy experiencing polypharmacy in a clinical setting and to identify patient factors associated with polypharmacy. Design and Setting This cross‐sectional study involved a retrospective review of medical records from initial visits at the Transitional and Lifelong Care (TLC) program, a specialized outpatient service for adolescents and adults with childhood onset disabilities at a rehabilitation hospital in London, Ontario, Canada.

Participants

All patients with a formal diagnosis of cerebral palsy who had an initial visit with the TLC program between October 2014 and December 2017 ( n = 307).

Interventions

Not applicable. Main Outcome Measures Based on the number of regularly scheduled medications recorded, patients taking ≥5 medications were identified as experiencing polypharmacy.

Results

Within the sample of 304 patients, 101 (33.2%) were experiencing polypharmacy (average: 7.9 ± 2.9 medications). Modified Poisson regression models were used to estimate the adjusted prevalence ratios (aPR) and 95% confidence intervals (CIs) for the association between patient factors and polypharmacy. Older age (aPR: 2.12; 95% CI: 1.19–3.77), higher Gross Motor Function Classification System (GMFCS) level (aPR: 1.59; 95% CI: 1.02–2.48), and epilepsy history (aPR: 1.64; 95% CI: 1.13–2.38) were associated with experiencing polypharmacy.

Conclusion

Polypharmacy is a common phenomenon among adolescent and adult patients with cerebral palsy in a clinical setting.

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
  • School of Physical Therapy, Faculty of Health Sciences, Western University, London, Ontario, Canada.
  • Department of Health & Rehabilitation Sciences, Faculty of Health Sciences, Western University, London, Ontario, Canada.

ORCID-Profile: Caitlin Cassidy

Förderung

  • Academic Medical Organization of Southwestern Ontario

Zitieren

APA

Cassidy, C., Wiener, J. C., Pratt, K., & Brunton, L. (2026). Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting. PM&R. https://doi.org/10.1002/pmrj.70135

Vancouver

Cassidy C, Wiener JC, Pratt K, Brunton L. Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting. PM&R. 2026. doi:10.1002/pmrj.70135

BibTeX
@article{Cassidy2026,
  author = {Cassidy, Caitlin and Wiener, Joshua C and Pratt, Karen and Brunton, Laura},
  title = {Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting},
  journal = {PM&R},
  year = {2026},
  doi = {10.1002/pmrj.70135}
}
Kostenlos starten →